|
2024
|
G/S
|
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products an... |
|
|
G/S
|
Pharmaceuticals; pharmaceutical preparations; pharmaceutical
products; pharmaceutical products a... |
|
|
G/S
|
Antibacterial pharmaceuticals; Cardiovascular pharmaceutical preparations; Contrast media for use... |
|
|
Invention
|
Bicyclic peptide ligands specific for nk cells. The present invention relates to polypeptides whi... |
|
|
Invention
|
Bicyclic peptide ligands specific for nectin-4 and uses thereof. The present invention relates to... |
|
|
Invention
|
Bicyclic peptide ligands specific for epha2 and uses thereof. The present invention relates to a ... |
|
|
G/S
|
Pharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid a... |
|
|
Invention
|
Synthesis of bicycle toxin conjugates, and intermediates thereof. The present invention relates m... |
|
2023
|
G/S
|
Pharmaceutical preparations for use in oncology for both solid and liquid tumors, metabolic disea... |
|
|
G/S
|
Pharmaceutical products, namely, pharmaceutical preparations for use in oncology; pharmaceutical ... |
|
|
G/S
|
Pharmaceutical products; pharmaceutical preparations;
pharmaceutical products for the treatment ... |
|
|
Invention
|
Anti-infective bicyclic peptide ligands. The present invention relates to polypeptides which are ... |
|
|
Invention
|
Bicyclic peptide ligands specific for transferrin receptor 1 (tfr1). The present invention relate... |
|
2022
|
Invention
|
Methods for treating cancer. The present invention relates to a heterotandem bicyclic peptide com... |
|
|
Invention
|
Novel use. The present invention relates to polypeptides which are covalently bound to molecular ... |
|
|
Invention
|
Bicyclic peptide ligand drug conjugates. The present invention relates to drug conjugates compris... |
|
|
Invention
|
Conjugated oligonucleotides and uses thereof. Provided herein are oligomeric compounds comprising... |
|
|
Invention
|
Synthesis of bicycle toxin conjugates, and intermediates thereof.
The present invention relates ... |
|
|
Invention
|
Synthesis of bicycle toxin conjugates, and intermediates thereof. The present invention relates t... |
|
|
Invention
|
Bicyclic peptide ligands specific for p-selectin. The present invention relates to polypeptides w... |
|
|
Invention
|
Bicyclic peptide ligands specific for trem2. The present invention relates to polypeptides which ... |
|
|
G/S
|
Pharmaceuticals, for use in the treatment and prevention of disease in the field of oncology for ... |
|
|
G/S
|
Pharmaceuticals, namely, preparations and products for use in the treatment and prevention of dis... |
|
|
G/S
|
Scientific and technological services and research and design relating thereto, namely, scientifi... |
|
|
G/S
|
Pharmaceutical products; pharmaceutical preparations. Scientific and technological services and r... |
|
|
Invention
|
Methods for treating cancer. The present invention relates to a method of treating a cancer in a ... |
|
|
Invention
|
Methods for treating cancer.
The present invention relates to a method of treating a cancer in a... |
|
|
Invention
|
Heterotandem bicyclic peptide complexes.
The present invention relates to heterotandem bicyclic ... |
|
|
Invention
|
Bicyclic peptide ligands specific for nk cells.
The present invention relates to polypeptides wh... |
|
|
Invention
|
Anti-infective bicyclic peptide ligands.
The present invention relates to multimers of polypepti... |
|
|
Invention
|
Anti-infective bicyclic peptide ligands. The present invention relates to multimers of polypeptid... |
|
|
Invention
|
Heterotandem bicyclic peptide complexes. The present invention relates to heterotandem bicyclic p... |
|
2021
|
Invention
|
Bicycle conjugates specific for nectin-4 and uses thereof. The present invention relates to a Bic... |
|
|
Invention
|
Peptide-based linkers. The invention relates to novel linkers which comprise two or three basic, ... |
|
|
Invention
|
Novel linkers.
The invention relates to novel linkers which comprise two or three basic, acidic ... |
|
|
Invention
|
Treatment of diseases characterized by overexpression of erythropoietin-producing hepatocellular ... |
|
|
Invention
|
Bicyclic peptide ligands specific for nectin-4 and uses thereof.
The present invention relates t... |
|
|
Invention
|
Anti-infective bicyclic peptide ligands.
The present invention relates to polypeptides which are... |
|
|
Invention
|
Anti-infective bicyclic peptide conjugates. The present invention relates to polypeptides which a... |
|
|
Invention
|
Bicyclic peptide ligands specific for tslp. The present invention relates to polypeptides which a... |
|
|
Invention
|
Anti-infective bicyclic peptide conjugates. The present invention relates to a polypeptides which... |
|
|
Invention
|
Pbp3 binding bicyclic peptide ligands. The present invention relates to polypeptides which are co... |
|
2020
|
Invention
|
Bicyclic peptide ligands specific for il-17.
The present invention relates to polypeptides which... |
|
|
Invention
|
Bicyclic peptide ligands specific for il-17. The present invention relates to polypeptides which ... |
|
|
Invention
|
Bicyclic peptide ligands specific for epha2 and uses thereof.
The present invention relates to a... |
|
|
G/S
|
Pharmaceutical products; pharmaceutical preparations; all
being for use in relation to oncology.... |
